Apex Gmbh

Munich D-81241

0 studies enrolling now · 6 studies all time

What they study most

Advanced Liver Fibrosis, Inflammatory Disease, Kidney Diseases, Liver Cirrhosis, Oncology, Renal Insufficiency, Rheumatoid Arthritis

Studies at this site

• A Study to Evaluate the Pharmacokinetics and Safety of INCB054707 in Participants With Normal Hepatic Function and Participants With Hepatic Impairment — Completed
• A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosis — Completed
• Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis — Completed
• Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function — Completed
• Pharmacokinetics of Lanraplenib in Adults With Impaired Renal Function — Completed
• Pharmacokinetics of Entospletinib in Adults With Normal and Impaired Liver Function — Completed